According to Lantheus Holdings's latest financial reports the company has $0.71 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.71 B | 71.7% |
2022-12-31 | $0.41 B | 321.95% |
2021-12-31 | $98.5 M | 23.74% |
2020-12-31 | $79.61 M | -14.32% |
2019-12-31 | $92.91 M | -18.06% |
2018-12-31 | $0.11 B | 48.64% |
2017-12-31 | $76.29 M | 49.07% |
2016-12-31 | $51.17 M | 78.97% |
2015-12-31 | $28.59 M | 44.87% |
2014-12-31 | $19.73 M | 6.25% |
2013-12-31 | $18.57 M | -44.25% |
2012-12-31 | $33.32 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Quotient QTNT | $11.93 M | -98.33% | ๐จ๐ญ Switzerland |
Cytosorbents CTSO | $14.13 M | -98.02% | ๐บ๐ธ USA |
Neogen NEOG | $0.23 B | -67.73% | ๐บ๐ธ USA |